BACE1 and Alzheimer disease: In support of elevated BACE1 activity, a study reported a significant rise in plasma BACE1 activity by 53.2% in subjects with MCI and by 68.9% in patients with AD and suggesting plasma BACE1 activity as a diagnostic biomarker [93].